Osnat Ben-Shahar

About Osnat Ben-Shahar

Osnat Ben-Shahar, With an exceptional h-index of 24 and a recent h-index of 13 (since 2020), a distinguished researcher at University of California, Santa Barbara, specializes in the field of Neural Mechanisms of Addiction.

His recent articles reflect a diverse array of research interests and contributions to the field:

The incubation of cocaine craving is dissociated from changes in glial cell markers within prefrontal cortex and nucleus accumbens of rats

Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients

A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma

A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone …

Osnat Ben-Shahar Information

University

Position

___

Citations(all)

2509

Citations(since 2020)

561

Cited By

2154

hIndex(all)

24

hIndex(since 2020)

13

i10Index(all)

32

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Osnat Ben-Shahar Skills & Research Interests

Neural Mechanisms of Addiction

Top articles of Osnat Ben-Shahar

The incubation of cocaine craving is dissociated from changes in glial cell markers within prefrontal cortex and nucleus accumbens of rats

Addiction neuroscience

2022/9

Osnat Ben-Shahar
Osnat Ben-Shahar

H-Index: 13

Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial

Journal of Clinical Oncology

2022/8/1

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients

British journal of cancer

2022/3/23

Osnat Ben-Shahar
Osnat Ben-Shahar

H-Index: 13

Andrew Decastro
Andrew Decastro

H-Index: 10

A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma

American journal of hematology

2022/2/1

A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone …

The American Journal of Case Reports

2022

Osnat Ben-Shahar
Osnat Ben-Shahar

H-Index: 13

See List of Professors in Osnat Ben-Shahar University(University of California, Santa Barbara)

Co-Authors

academic-engine